Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27
Saved in:
| Main Authors: | Yong Wang, Yanan Wang, Lei Bao, Goncalo Vale, Jeffrey G. McDonald, Yisheng Fang, Yan Peng, Ashwani Kumar, Chao Xing, Fara Brasó-Maristany, Aleix Prat, Carlos L. Arteaga, Yingfei Wang, Weibo Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60137-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27
by: Yong Wang, et al.
Published: (2025-04-01) -
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P
by: David F. Moreno, et al.
Published: (2025-07-01) -
Deciphering the transcriptomic landscape of early HR+/HER2− breast cancer in very young women
by: Iris Garrido‐Cano, et al.
Published: (2025-07-01) -
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8
by: Ying Yang, et al.
Published: (2025-04-01) -
Molecular Insights into Outer Dynein Arm Defects in Primary Ciliary Dyskinesia: Involvement of ZMYND10 and GRP78
by: İlker Levent Erdem, et al.
Published: (2025-06-01)